Literature DB >> 8542666

Bile acid malabsorption: mechanisms and treatment.

S Eusufzai1.   

Abstract

Bile acid malabsorption is often due to a disease or partial resection of the terminal ileum and more rarely a genetic defect in the distal ileum. It is often associated with diarrhoea with or without steatorrhoea, and it may be complicated by gallstone disease and hyperoxaluria. Bile acid malabsorption is rather easily diagnosed using the selenohomocholic acid taurine test. Patients with bile acid induced diarrhoea should be recommended a low-fat diet. Cholestyramine may be recommended in moderate bile acid diarrhoea. In patients with more severe bile acid malabsorption, cholylsarcosine may be used as a replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542666     DOI: 10.1159/000171511

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

1.  [Metabolic long-term complications after urinary diversion].

Authors:  R Stein; C Ziesel; S Frees; J W Thüroff
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

2.  [Urinary diversion in childhood: special attention to the long-term consequences and complications].

Authors:  R Stein; A Schröder; J W Thüroff
Journal:  Urologe A       Date:  2011-05       Impact factor: 0.639

3.  Effect of bile salts on colonic mucus secretion in isolated vascularly perfused rat colon.

Authors:  A Barcelo; J Claustre; F Toumi; G Burlet; J A Chayvialle; J C Cuber; P Plaisancié
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

4.  Bile Acid malabsorption.

Authors:  Henrik Westergaard
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

Review 5.  Intestinal bile acid physiology and pathophysiology.

Authors:  Olga Martinez-Augustin; Fermin Sanchez de Medina
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

Review 6.  Metabolic consequences after urinary diversion.

Authors:  Raimund Stein; Peter Rubenwolf
Journal:  Front Pediatr       Date:  2014-03-10       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.